These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1092440)

  • 1. Lethality of Candida strains as influenced by the host.
    Saltarelli CG; Gentile KA; Mancuso SC
    Can J Microbiol; 1975 May; 21(5):648-54. PubMed ID: 1092440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenicity of 5-fluorocytosine resistant strains of Candida albicans.
    Fasoli MO; Kerridge D; Ryley JF
    J Med Vet Mycol; 1990; 28(1):27-34. PubMed ID: 2194016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative virulence of Candida albicans strains in CFW1 mice and Sprague-Dawley rats.
    Schmidt A; Geschke U
    Mycoses; 1996; 39(5-6):157-60. PubMed ID: 8909024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germ tube formation and proteinase activity of Candida albicans in relation to virulence for mice.
    Okamoto K; Ashimoto A; Tanaka Y; Hamada T
    Kansenshogaku Zasshi; 1993 May; 67(5):466-72. PubMed ID: 8320464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CAP1, an adenylate cyclase-associated protein gene, regulates bud-hypha transitions, filamentous growth, and cyclic AMP levels and is required for virulence of Candida albicans.
    Bahn YS; Sundstrom P
    J Bacteriol; 2001 May; 183(10):3211-23. PubMed ID: 11325951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenicity in mice of strains of Candida albicans (Robin) Berk. isolated from burn patients.
    Albano MM; Schmitt JA
    Mycopathol Mycol Appl; 1973 Apr; 49(4):283-8. PubMed ID: 4575393
    [No Abstract]   [Full Text] [Related]  

  • 7. Low virulence of a morphological Candida albicans mutant.
    Diez-Orejas R; Molero G; Ríos-Serrano I; Vázquez A; Gil C; Nombela C; Sánchez-Pérez M
    FEMS Microbiol Lett; 1999 Jul; 176(2):311-9. PubMed ID: 10427713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virulence for mice of a proteinase-secreting strain of Candida albicans and a proteinase-deficient mutant.
    Macdonald F; Odds FC
    J Gen Microbiol; 1983 Feb; 129(2):431-8. PubMed ID: 6341508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteinase production and pathogenicity of Candida albicans. II. Virulence for mice of C. albicans strains of different proteinase activity.
    Kondoh Y; Shimizu K; Tanaka K
    Microbiol Immunol; 1987; 31(11):1061-9. PubMed ID: 3328042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of pathogenicity of various Candida albicans and C. stellatoidea strains.
    Okawa Y; Miyauchi M; Takahashi S; Kobayashi H
    Biol Pharm Bull; 2007 Oct; 30(10):1870-3. PubMed ID: 17917253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival in experimental Candida albicans infections depends on inoculum growth conditions as well as animal host.
    Odds FC; Van Nuffel L; Gow NAR
    Microbiology (Reading); 2000 Aug; 146 ( Pt 8)():1881-1889. PubMed ID: 10931892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of the NRG1 repressor controls species-specific regulation of chlamydospore development in Candida albicans and Candida dubliniensis.
    Staib P; Morschhäuser J
    Mol Microbiol; 2005 Jan; 55(2):637-52. PubMed ID: 15659176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenicity of morphological and auxotrophic mutants of Candida albicans in experimental infections.
    Shepherd MG
    Infect Immun; 1985 Nov; 50(2):541-4. PubMed ID: 3902649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The yeast to hyphal transition following hematogenous candidiasis induces shock and organ injury independent of circulating tumor necrosis factor-alpha.
    Matuschak GM; Lechner AJ
    Crit Care Med; 1997 Jan; 25(1):111-20. PubMed ID: 8989186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase of virulence and its phenotypic traits in drug-resistant strains of Candida albicans.
    Angiolella L; Stringaro AR; De Bernardis F; Posteraro B; Bonito M; Toccacieli L; Torosantucci A; Colone M; Sanguinetti M; Cassone A; Palamara AT
    Antimicrob Agents Chemother; 2008 Mar; 52(3):927-36. PubMed ID: 18180350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exoenzyme activity and possibility identification of Candida dubliniensis among Candida albicans species isolated from vaginal candidiasis.
    Jafari M; Salari S; Pakshir K; Zomorodian K
    Microb Pathog; 2017 Sep; 110():73-77. PubMed ID: 28642006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between virulence of Candida albicans mutants in mice and Galleria mellonella larvae.
    Brennan M; Thomas DY; Whiteway M; Kavanagh K
    FEMS Immunol Med Microbiol; 2002 Oct; 34(2):153-7. PubMed ID: 12381467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic infection following intravenous inoculation of mice with Candida albicans int1 mutant strains.
    Bendel CM; Kinneberg KM; Jechorek RP; Gale CA; Erlandsen SL; Hostetter MK; Wells CL
    Mol Genet Metab; 1999 Aug; 67(4):343-51. PubMed ID: 10444345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenicity and virulence of Candida dubliniensis: comparison with C. albicans.
    Vilela MM; Kamei K; Sano A; Tanaka R; Uno J; Takahashi I; Ito J; Yarita K; Miyaji M
    Med Mycol; 2002 Jun; 40(3):249-57. PubMed ID: 12146754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in virulence of clinical isolates of Candida tropicalis and Candida albicans in mice.
    Wingard JR; Dick JD; Merz WG; Sandford GR; Saral R; Burns WH
    Infect Immun; 1982 Aug; 37(2):833-6. PubMed ID: 6749689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.